Sutro Biopharma, Inc.
STRO
$30.52
$0.973.28%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 202.56M | 141.43M | 167.59M | 205.13M | 248.97M |
| Total Receivables | 12.48M | 3.98M | 3.92M | 8.00M | 13.56M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 5.43M | 5.52M | 10.60M | 18.50M | 24.88M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 500.00K | -- | -- | -- | -- |
| Total Current Assets | 220.97M | 150.93M | 182.11M | 231.63M | 287.41M |
|
|
|||||
| Total Current Assets | 220.97M | 150.93M | 182.11M | 231.63M | 287.41M |
| Net Property, Plant & Equipment | 19.07M | 21.55M | 26.69M | 29.82M | 33.08M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.95M | 1.35M | 858.00K | 908.00K | 943.00K |
| Total Assets | 241.99M | 173.83M | 209.66M | 262.36M | 321.43M |
|
|
|||||
| Total Accounts Payable | 5.49M | 7.57M | 7.03M | 4.31M | 8.18M |
| Total Accrued Expenses | 33.04M | 46.31M | 32.14M | 49.92M | 33.95M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 7.60M | 7.78M | 7.96M | 8.06M | 7.77M |
| Total Finance Division Other Current Liabilities | 24.68M | 13.48M | 24.77M | 11.96M | 83.15M |
| Total Other Current Liabilities | 24.68M | 13.48M | 24.77M | 11.96M | 83.15M |
| Total Current Liabilities | 70.81M | 75.13M | 71.90M | 74.25M | 133.05M |
|
|
|||||
| Total Current Liabilities | 70.81M | 75.13M | 71.90M | 74.25M | 133.05M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 6.03M | 7.89M | 9.70M | 11.54M | 13.63M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 232.03M | 223.26M | 215.33M | 208.68M | 200.56M |
| Total Liabilities | 308.88M | 306.28M | 296.93M | 294.47M | 347.24M |
|
|
|||||
| Common Stock & APIC | 949.65M | 845.48M | 843.89M | 842.24M | 837.04M |
| Retained Earnings | -1.02B | -977.96M | -931.19M | -874.34M | -862.84M |
| Treasury Stock & Other | -101.00K | 19.00K | 33.00K | -13.00K | -9.00K |
| Total Common Equity | -66.89M | -132.45M | -87.27M | -32.11M | -25.81M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -66.89M | -132.45M | -87.27M | -32.11M | -25.81M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -66.89M | -132.45M | -87.27M | -32.11M | -25.81M |
|
|
|||||